Patent · US Active

Compositions and methods for modulating factor IX function

US10676731B2 · kind B2 · utility

0Cited by
15References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 2015
Grant dateJun 9, 2020
Priority date—
Expiry dateJun 3, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Factor IX/IXa variants and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.